Dr. Rudi E. Moerck
President of Valensa International
Dr. Rudi Moerck holds a BS degree in Biology from Florida Southern College and holds a Ph.D. in Organic Chemistry from the University of Florida. He was a NIH postdoctoral fellow at Ohio State and taught chemistry at Ohio State and also at Ohio Wesleyan University.
His career in the life sciences industry has been wide and varied covering a span of over 30 years. It includes being the principal inventor of RenaZorb, a new kidney drug currently undergoing clinical trials for FDA approval. He worked for several public companies including positions as President of Altair Nanotechnologies (ALTI) and president of the Pharmaceutical Division of Cambrex (CBM). He held the position of VP and General Manager of Catalytica Pharmaceuticals, and was also Vice President of Peroxygens at Degussa AG and Degussa Coporation.
Dr. Moerck speaks fluent German having had extensive international experience both working and living in Chile, Switzerland and Germany.
In 2005 Dr. Moerck became President of Valensa International, leading the management team in implementing a new corporate strategy focused on turning the company into a science-based developer of botanically sourced products for human health and well-being. He is an expert in the benefits of astaxanthin and krill oil.
For more inforamation, visit Valensa.com.